Trodelvy did not meet the primary endpoint of progression-free survival in the ASCENT-07 trial for HR-positive, HER2-negative ...

MSK played a central role in the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC)’s landmark decision in April 2024 to accept measurable residual disease (MRD) as an ...

The hazard ratio (HR) for the primary endpoint was (3.84, p = 0.0009) in the first month The Prolocor pFCG™ test has the potential to help providers reduce 30-day readmission rates for Acute MI, an ...

SAN FRANCISCO -- Investigational gefurulimab met its primary efficacy endpoint in adults with anti-acetylcholine receptor ...

Despite the trial failure, Sarepta will still seek full approval of AMONDYS 45 and VYONDYS 53 in DMD from the FDA.

About 15 years ago, Carl Ola Landgren, M.D. Ph.D., noticed an encouraging yet potentially concerning trend in the treatment of multiple myeloma. Drugs had become so increasingly efficacious that they ...

Changes to primary endpoints in phase 3 cancer trials occur frequently and are often undisclosed in study manuscripts, new research shows. Among 755 randomized controlled cancer trials registered in ...

The age of hybrid work is here. 76% of companies say they have shifted to a hybrid work strategy, splitting work hours between an office and remote environment. Only 11% of teams say they’re planning ...

Gilead Sciences (GILD) announced on Friday that a Phase 3 trial for its FDA-approved antibody-drug conjugate Trodelvy failed ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More In February, Nvidia was hit with a cyberattack by Lapsus$, an ...

The rapid pace of digital transformation has increased operational efficiency and enhanced the customer experience – but it has also created a nightmare for CISOs. From mobile devices scattered across ...